01-03 Zhongshan Daily & Zhongshan International Communications Center

ZHONGSHAN,China,Dec. 29,2024-- A report fromZhongshan Daily & Zhongshan International Communications Center:

01-03 CCSC Technology International Holdings Limited

HONG KONG,Dec. 28,2024--CCSC Technology International Holdings Limited (the "Company" or "CCSC") (Nasdaq: CCTG),a Hong Kong-based company that engages in the sale,design and manufa

01-03 The Brand Promise

HO CHI MINH CITY,Vietnam,Dec. 28,2024--After six months of preparation,HOTLIST 2024,one of Vietnam\'s most prestigious events in the tourism industry,concluded with resounding success at Hotel Nikko S

01-03 SynerK

SUZHOU,China,Dec. 30,2024-- Hangzhou Sino-US Huadong Medicine Co.,Ltd. (hereinafter referred to as "Huadong Medicine"),a wholly-owned subsidiary of Huadong Medicine Co.,Ltd. (SZ.000963),and

01-03 China Daily

BEIJING,Dec. 30,2024-- A report from China Daily: Episode 1 of the new season of the documentary This is China will explore the freight systems of the world.

01-03 Smartee Denti-Technology

SHANGHAI,Dec. 30,2024-- Smartee Denti-Technology,a leading innovator in the orthodontics industry,is thrilled to announce the launch of its new Disney-licensed product - Smartee Ge Clear Aligner packa

01-03 Telix Pharmaceuticals Limited

MELBOURNE,Australia and BRUSSELS,Dec. 31,2024-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company)and the Brussels-based Oncidium foundation today announce that results for the

01-03 SJ Semiconductor Corporation

JIANGYIN,China,Dec. 31,2024-- SJ Semiconductor Corporation (hereinafter referred to as "SJSemi" or "the company") announced the efficient and successful closure of a new financing

01-03 New Oriental Education and Technology Group Inc.

BEIJING,Dec. 31,2024-- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK),a provider of private educational services in China

01-03 MicuRx Pharmaceuticals

SHANGHAI,Jan. 2,2025-- Shanghai MicuRx Pharmaceutical Co.,Ltd. ("MicuRx"，688373.SH) announced that MRX-5,its self-developed anti-infection drug,has been granted Orphan Drug Designation (ODD